{
    "root": "eac3cec2-b373-4936-89f0-c6d300e09f6e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution"
    },
    "value": "20250310",
    "ingredients": [
        {
            "name": "BRIMONIDINE TARTRATE",
            "code": "4S9CL2DY2H"
        },
        {
            "name": "TIMOLOL MALEATE",
            "code": "P8Y54F701R"
        },
        {
            "name": "BENZALKONIUM CHLORIDE",
            "code": "F5UM2KM3W7"
        },
        {
            "name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
            "code": "593YOG76RN"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE",
            "code": "70WT22SF4B"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        }
    ],
    "indications": "Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP; the IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day.",
    "contraindications": "The recommended dose is one drop of brimonidine tartrate/timolol maleate ophthalmic solution in the affected eye(s) twice daily approximately 12 hours apart. If more than one topical ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.",
    "warningsAndPrecautions": "Brimonidine tartrate/timolol maleate ophthalmic solution is supplied sterile, in a white low density polyethylene (LDPE) bottle with a white LDPE nozzle and dark blue HDPE caps as follows:\n                   5 mL in 10 mL bottle       NDC 65145-162-01 10 mL in 10 mL bottle     NDC 65145-163-01 15 mL in 15 mL bottle     NDC 65145-164-01\n                  \n                     Storage: Store at 20° -25°C (68° -77°F) [See USP Controlled Room Temperature]. Protect from light.",
    "adverseReactions": "Bronchial asthma, a history of bronchial asthma, severe chronic obstructive pulmonary disease. ( 4.1 , 5.1 , 5.3 ) Sinus bradycardia, atrioventricular block, overt cardiac failure, cardiogenic shock. ( 4.2 , 5.2 ) Neonates and infants (under the age of 2 years). ( 4.3 ) Hypersensitivity to any component of this product. ( 4.4 )"
}